MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Open Access
- 5 January 2015
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 212 (1) , 5-14
Abstract
Innate immune receptors for pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2–deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2–HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4–MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.Keywords
This publication has 29 references indexed in Scilit:
- Lipopolysaccharide Clearance, Bacterial Clearance, and Systemic Inflammatory Responses Are Regulated by Cell Type–Specific Functions of TLR4 during SepsisThe Journal of Immunology, 2013
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine releaseJournal of Experimental Medicine, 2012
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and InfectionAnnual Review of Immunology, 2011
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine releaseProceedings of the National Academy of Sciences, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- MD-2-mediated Ionic Interactions between Lipid A and TLR4 Are Essential for Receptor ActivationJournal of Biological Chemistry, 2010
- Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H MiceJournal of Virology, 2009
- CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune ResponsesScience, 2009
- Isolation of Monomeric and Dimeric Secreted MD-2Journal of Biological Chemistry, 2008
- Role of HMGB1 in apoptosis-mediated sepsis lethalityJournal of Experimental Medicine, 2006